Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Biotech
Bright Minds seizure study on partial hold over toxicity in mice
The FDA put a partial hold on the seizure study application over preclinical toxicity data and concerns about its preparations for enrolling children.
Nick Paul Taylor
Nov 2, 2026 8:43am
Gilead reveals partial clinical hold on 2 CAR-T trials
Oct 30, 2026 10:04am
Biohaven epilepsy drug suffers FDA hold days after $350M deal
Sep 10, 2026 10:03am
Regenxbio gene therapy refiling plan derailed by FDA hold
Aug 24, 2026 7:51am
After trimming headcount, Aardvark drops trials as wait drags on
Aug 12, 2026 9:03am
Aardvark to dig into phase 3 data early after FDA imposes hold
May 15, 2026 1:51am